Staged total percutaneous treatment of aortic valve pathology and mitral regurgitation: Institutional experience

Catheterization and Cardiovascular Interventions

Volumn 82, Issue 4, 2013, Pages

  Kische, Stephan ^a   D'Ancona, Giuseppe ^a   Paranskaya, Liliya ^a   Schubert, Jochen ^a   Arsoy, Nicole ^a   Hauenstein, Karl Heinz ^a   Alozie, Anthony ^a   Jovanovich, Bojan ^a   Nienaber, Christoph ^a   Ince, Hüseyin ^a  

^a ROSTOCK UNIVERSITY MEDICAL CENTER   (Germany)

Author keywords

CHF, congestive heart failure; IMCT, imaging (CT); VALV; valvular heart disease

Indexed keywords

AGED; AORTA VALVE STENOSIS; ARTICLE; CLINICAL ARTICLE; CLIP; DISEASE EXACERBATION; DISEASE SEVERITY; ECHOCARDIOGRAPHY; FEASIBILITY STUDY; FEMALE; FOLLOW UP; FUNCTIONAL STATUS; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MALE; MITRAL VALVE REGURGITATION; MITRAL VALVE REPAIR; OUTCOME ASSESSMENT; PATIENT SAFETY; PERCUTANEOUS AORTIC VALVE; POSTOPERATIVE CARE; PREOPERATIVE PERIOD; PROSPECTIVE STUDY; SCORING SYSTEM; SURGICAL RISK; TRANSCATHETER AORTIC VALVE IMPLANTATION;

CHF, CONGESTIVE HEART FAILURE; IMCT, IMAGING (CT); VALV; VALVULAR HEART DISEASE;

AGED; AGED, 80 AND OVER; AORTIC VALVE; AORTIC VALVE INSUFFICIENCY; AORTIC VALVE STENOSIS; CARDIAC CATHETERIZATION; ECHOCARDIOGRAPHY, DOPPLER, COLOR; FEASIBILITY STUDIES; FEMALE; GERMANY; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; LENGTH OF STAY; MALE; MITRAL VALVE INSUFFICIENCY; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; STROKE VOLUME; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

EID: 84885021658     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.24809     Document Type: Article

References (39)

1. Whitlow PL, Feldman T, Pedersen WR, Lim DS, Kipperman R, Smalling R, Bajwa T, Herrmann HC, Lasala J, Maddux JT, Tuzcu M, Kapadia S, Trento A, Siegel RJ, Foster E, Glower D, Mauri L, Kar S,; EVEREST II Investigators. Acute and 12-month results with catheter-based mitral valve leaflet repair: The EVEREST II (Endovascular Valve Edge-to-Edge Repair) High Risk Study. J Am Coll Cardiol 2012; 59: 130-139.
2. Kodali SK, Williams MR, Smith CR, Svensson LG, Webb JG, Makkar RR, Fontana GP, Dewey TM, Thourani VH, Pichard AD, Fischbein M, Szeto WY, Lim S, Greason KL, Teirstein PS, Malaisrie SC, Douglas PS, Hahn RT, Whisenant B, Zajarias A, Wang D, Akin JJ, Anderson WN, Leon MB,; PARTNER Trial Investigators. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med 2012; 366: 1686-1695.
3. Makkar RR, Fontana GP, Jilaihawi H, Kapadia S, Pichard AD, Douglas PS, Thourani VH, Babaliaros VC, Webb JG, Herrmann HC, Bavaria JE, Kodali S, Brown DL, Bowers B, Dewey TM, Svensson LG, Tuzcu M, Moses JW, Williams MR, Siegel RJ, Akin JJ, Anderson WN, Pocock S, Smith CR, Leon MB,; PARTNER Trial Investigators. Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. N Engl J Med 2012; 366: 1696-1704.
4. Rudolph V, Schirmer J, Franzen O, Schluter M, Seiffert M, Treede H, Reichenspurner H, Blankenberg S, Baldus S,. Bivalvular transcatheter treatment of high-surgical-risk patients with coexisting severe aortic stenosis and significant mitral regurgitation. Int J Cardiol 2012 Mar 27. [Epub ahead of print].
5. Puls M, Seipelt R, Schillinger W,. Complete interventional heart repair of multiple concomitant cardiac pathologies in a staged approach. Catheter Cardiovasc Interv 2013; 81: 896-900.
6. Madder RD, Safian RD, Gallagher M, Senter SR, Hanzel GS,. The first report of transcatheter aortic valve implantation and percutaneous mitral valve repair in the same patient. JACC Cardiovasc Interv 2011; 4: 824.
7. Ong SH, Beucher H, Mueller R, Gerckens U, Boekstegers P,. Percutaneous double-valve interventions for aortic stenosis and pure mitral regurgitation. Am J Cardiol 2011; 108: 893-895.
8. Barbanti M, Ussia GP, Tamburino C,. Percutaneous treatment of aortic stenosis and mitral regurgitation in the same patient: First human cases description. Catheter Cardiovasc Interv 2011; 78: 650-655.
9. Surder D, Altwegg L, Hurlimann D, Felix C, Grunenfelder J, Corti R,. Percutaneous double valve intervention. Eur Heart J 2011; 32: 636.
10. Piazza N, Grube E, Gerckens U, den Heijer P, Linke A, Luha O, Ramondo A, Ussia G, Wenaweser P, Windecker S, Laborde JC, de Jaegere P, Serruys PW,. Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) corevalve revalving system: Results from the multicentre, expanded evaluation registry 1-year following CE mark approval. EuroIntervention 2008; 4: 242-249.
11. Masson JB, Kovac J, Schuler G, Ye J, Cheung A, Kapadia S, Tuzcu ME, Kodali S, Leon MB, Webb JG,. Transcatheter aortic valve implantation: Review of the nature, management, and avoidance of procedural complications. JACC Cardiovasc Interv 2009; 2: 811-820.
12. Feldman T, Foster E, Glower DD, Kar S, Rinaldi MJ, Fail PS, Smalling RW, Siegel R, Rose GA, Engeron E, Loghin C, Trento A, Skipper ER, Fudge T, Letsou GV, Massaro JM, Mauri L,; EVEREST II Investigators. Percutaneous repair or surgery for mitral regurgitation. N Engl J Med 2011; 364: 1395-1406.
13. Kische S, Nienaber C, Ince H,. Use of four MitraClip devices in a patient with ischemic cardiomyopathy and mitral regurgitation: "Zipping by Clipping". Catheter Cardiovasc Interv 2011; 80: 1007-1013.
14. Divchev D, Kische S, Paranskaya L, Schneider H, Rehders T, Ortak J, Akin I, Turan G, Turan CH, Steinhoff G, Nöldge-Schomburg G, Nienaber CA, Ince H,. In-hospital outcome of patients with severe mitral valve regurgitation classified as inoperable and treated with the mitraclip((R)) device. J Interv Cardiol 2012; 25: 180-189.
15. Zoghbi WA, Enriquez-Sarano M, Foster E, Grayburn PA, Kraft CD, Levine RA, Nihoyannopoulos P, Otto CM, Quinones MA, Rakowski H, Stewart WJ, Waggoner A, Weissman NJ,; American Society of Echocardiography. Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr 2003; 16: 777-802.
16. Baumgartner H, Hung J, Bermejo J, Chambers JB, Evangelista A, Griffin BP, Iung B, Otto CM, Pellikka PA, Quinones M,. Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. J Am Soc Echocardiogr 2009; 22: 1-23; quiz 101-102.
17. Foster E, Wasserman HS, Gray W, Homma S, Di Tullio MR, Rodriguez L, Stewart WJ, Whitlow P, Block P, Martin R, Merlino J, Herrmann HC, Wiegers SE, Silvestry FE, Hamilton A, Zunamon A, Kraybill K, Gerber IL, Weeks SG, Zhang Y, Feldman T,. Quantitative assessment of severity of mitral regurgitation by serial echocardiography in a multicenter clinical trial of percutaneous mitral valve repair. Am J Cardiol 2007; 100: 1577-1583.
18. Hannan EL, Racz MJ, Jones RH, Gold JP, Ryan TJ, Hafner JP, Isom OW,. Predictors of mortality for patients undergoing cardiac valve replacements in New York State. Ann Thorac Surg 2000; 70: 1212-1218.
19. Gillinov AM, Blackstone EH, Cosgrove DM III, White J, Kerr P, Marullo A, McCarthy PM, Lytle BW,. Mitral valve repair with aortic valve replacement is superior to double valve replacement. J Thorac Cardiovasc Surg 2003; 125: 1372-1387.
20. Leavitt BJ, Baribeau YR, DiScipio AW, Ross CS, Quinn RD, Olmstead EM, Sisto D, Likosky DS, Cochran RP, Clough RA, Boss RA Jr, Kramer RS, O'Connor GT,; Northern New England Cardiovascular Disease Study Group. Outcomes of patients undergoing concomitant aortic and mitral valve surgery in northern new England. Circulation 2009; 120 (11 Suppl): S155-S162.
21. Mueller XM, Tevaearai HT, Stumpe F, Fischer AP, Hurni M, Ruchat P, von Segesser LK,. Long-term results of mitral-aortic valve operations. J Thorac Cardiovasc Surg 1998; 115: 1298-1309.
22. Ambler G, Omar RZ, Royston P, Kinsman R, Keogh BE, Taylor KM,. Generic, simple risk stratification model for heart valve surgery. Circulation 2005; 112: 224-231.
23. Bonow RO, Carabello BA, Chatterjee K, de Leon AC Jr, Faxon DP, Freed MD, Gaasch WH, Lytle BW, Nishimura RA, O'Gara PT, O'Rourke RA, Otto CM, Shah PM, Shanewise JS,;, 2006, Writing Committee Members; American College of Cardiology/American Heart Association Task Force. 2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation 2008; 118: e523-e661.
24. Alghamdi AA, Elmistekawy EM, Singh SK, Latter DA,. Is concomitant surgery for moderate functional mitral regurgitation indicated during aortic valve replacement for aortic stenosis? A systematic review and evidence-based recommendations. J Card Surg 2010; 25: 182-187.
25. Waisbren EC, Stevens LM, Avery EG, Picard MH, Vlahakes GJ, Agnihotri AK,. Changes in mitral regurgitation after replacement of the stenotic aortic valve. Ann Thorac Surg 2008; 86: 56-62.
26. Tassan-Mangina S, Metz D, Nazeyllas P, Torossian F, Pop C, Bertrand J, Baehrel B, Elaerts J,. Factors determining early improvement in mitral regurgitation after aortic valve replacement for aortic valve stenosis: A transthoracic and transesophageal prospective study. Clin Cardiol 2003; 26: 127-131.
27. Harris KM, Malenka DJ, Haney MF, Jayne JE, Hettleman B, Plehn JF, Griffin BP,. Improvement in mitral regurgitation after aortic valve replacement. Am J Cardiol 1997; 80: 741-745.
28. Vanden Eynden F, Bouchard D, El-Hamamsy I, Butnaru A, Demers P, Carrier M, Perrault LP, Tardif JC, Pellerin M,. Effect of aortic valve replacement for aortic stenosis on severity of mitral regurgitation. Ann Thorac Surg 2007; 83: 1279-1284.
29. Matsumura Y, Gillinov AM, Toyono M, Oe H, Yamano T, Takasaki K, Saraiva RM, Shiota T,. Echocardiographic predictors for persistent functional mitral regurgitation after aortic valve replacement in patients with aortic valve stenosis. Am J Cardiol 2010; 106: 701-706.
30. Ruel M, Kapila V, Price J, Kulik A, Burwash IG, Mesana TG,. Natural history and predictors of outcome in patients with concomitant functional mitral regurgitation at the time of aortic valve replacement. Circulation 2006; 114 (1 Suppl): I541-I546.
31. D'Onofrio A, Gasparetto V, Napodano M, Bianco R, Tarantini G, Renier V, Isabella G, Gerosa G,. Impact of preoperative mitral valve regurgitation on outcomes after transcatheter aortic valve implantation. Eur J Cardiothorac Surg 2012; 41: 1271-1277.
32. Durst R, Avelar E, McCarty D, Poh KK, Friera LF, Llano MF, Chu J, Anumandla AK, Rodriguez LL, Mack MJ, Hanzel G, Kodali SK, Hung J, Picard MH,. Outcome and improvement predictors of mitral regurgitation after transcatheter aortic valve implantation. J Heart Valve Dis 2011; 20: 272-281.
33. Tzikas A, Piazza N, van Dalen BM, Schultz C, Geleijnse ML, van Geuns RJ, Galema TW, Nuis RJ, Otten A, Gutierrez-Chico JL, Serruys PW, de Jaegere PP,. Changes in mitral regurgitation after transcatheter aortic valve implantation. Catheter Cardiovasc Interv 2010; 75: 43-49.
34. Hekimian G, Detaint D, Messika-Zeitoun D, Attias D, Iung B, Himbert D, Brochet E, Vahanian A,. Mitral regurgitation in patients referred for transcatheter aortic valve implantation using the Edwards Sapien prosthesis: Mechanisms and early postprocedural changes. J Am Soc Echocardiogr 2012; 25: 160-165.
35. Tamburino C, Capodanno D, Ramondo A, Petronio AS, Ettori F, Santoro G, Klugmann S, Bedogni F, Maisano F, Marzocchi A, Poli A, Antoniucci D, Napodano M, De Carlo M, Fiorina C, Ussia GP,. Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis. Circulation 2011; 123: 299-308.
36. Rodés-Cabau J, Webb JG, Cheung A, Ye J, Dumont E, Feindel CM, Osten M, Natarajan MK, Velianou JL, Martucci G, DeVarennes B, Chisholm R, Peterson MD, Lichtenstein SV, Nietlispach F, Doyle D, DeLarochellière R, Teoh K, Chu V, Dancea A, Lachapelle K, Cheema A, Latter D, Horlick E,. Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: Acute and late outcomes of the multicenter Canadian experience. J Am Coll Cardiol 2010; 55: 1080-1090.
37. Toggweiler S, Boone RH, Rodés-Cabau J, Humphries KH, Lee M, Nombela-Franco L, Bagur R, Willson AB, Binder RK, Gurvitch R, Grewal J, Moss R, Munt B, Thompson CR, Freeman M, Ye J, Cheung A, Dumont E, Wood DA, Webb JG,. Transcatheter aortic valve replacement: Outcomes of patients with moderate or severe mitral regurgitation. J Am Coll Cardiol 2012; 59: 2068-2074.
38. Tamburino C, Ussia GP, Maisano F, Capodanno D, La Canna G, Scandura S, Colombo A, Giacomini A, Michev I, Mangiafico S, Cammalleri V, Barbanti M, Alfieri O,. Percutaneous mitral valve repair with the MitraClip system: Acute results from a real world setting. Eur Heart J 2010; 31: 1382-1389.
39. Franzen O, van der Heyden J, Baldus S, Schlüter M, Schillinger W, Butter C, Hoffmann R, Corti R, Pedrazzini G, Swaans MJ, Neuss M, Rudolph V, Sürder D, Grünenfelder J, Eulenburg C, Reichenspurner H, Meinertz T, Auricchio A,. MitraClip(R) therapy in patients with end-stage systolic heart failure. Eur J Heart Fail 2011; 13: 569-576.